| Overview |
| bsm-61664r-fitc-100ul |
| C-REL Recombinant Antibody, FITC Conjugated |
| WB |
| Human |
| Specifications |
| FITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human c Rel |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 5966 |
| Q04864 |
| Nucleus |
| Avian reticuloendotheliosis; c Rel proto oncogene protein; Oncogene REL; Proto-oncogene c-Rel; REL. |
| Proto-oncogene that may play a role in differentiation and lymphopoiesis. NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz